Depomed appoints new CMO
This article was originally published in Scrip
Newark, California-based Depomed, a specialty pharmaceutical company that commercializes products for pain and neurology related disorders, has named Dr Srinivas G Rao chief medical officer and senior vice-president. Dr Rao, the founder and CEO of Kyalin Biosciences, a privately held biotechnology company acquired by Retrophin in 2013, was most recently executive vice-president and head of neuroscience at Retrophin.
You may also be interested in...
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.